Veeva Systems (VEEV) is climbing 7% after delivering stronger-than-expected fourth-quarter results and providing full-year earnings per share guidance that came in above analysts' average estimate ...

In this article, we are going to take a look at where Veeva Systems Inc. (NYSE:VEEV) stands against the other health information services stocks. Health Information Services stocks have become a ...

Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the ...

Wide-moat Veeva reported solid fourth-quarter results that came in slightly ahead of our forecasts. Total sales of $720 million grew 14% year over year, driven by strong performance in both the ...

Subscription services revenue rose to $608.6 million, marking a 16.7% year-over-year growth. Veeva Systems exceeded earnings expectations for Q4 2025, while demonstrating solid revenue growth and ...

Subscription services revenue jumped 19% year over year, totaling $561.3 million. Veeva Systems reported strong earnings, surpassing management's expectations across several key metrics.

In a report released today, Allan Verkhovski from Scotiabank maintained a Hold rating on Veeva Systems (VEEV – Research Report), with a price target of $240.00. The company’s shares closed ...

Veeva (VEEV) Systems announced that Direct Data API is now included for no additional license fee as part of Veeva Vault Platform. Veeva Direct Data API is a new class of API that makes Veeva ...

Veeva Systems is a leading global provider of cloud software solutions for life sciences companies such as drugmakers, biotech companies and medical device makers. The company is steadily growing ...

Veeva is the leading provider of cloud-based software solutions tailored to the life sciences industry. It provides an ecosystem of products to address the operating challenges and regulatory ...